Abstract:Objectives: The goal of our bioinformatics study was to comprehensively analyze the association between the whole calpain family members and the progression and prognosis of hepatocellular carcinoma (HCC). Methods: The data were collected from The Cancer Genome Atlas (TCGA). The landscape of the gene expression, copy number variation (CNV), mutation, and DNA methylation of calpain members were analyzed. Clustering analysis was performed to stratify the calpain-related groups. The least absolute shrinkage and selection operator (LASSO)-based Cox model was used to select hub survival genes. Results: We found 14 out of 16 calpain members expressed differently between tumor and normal tissues of HCC. The clustering analyses revealed high- and low-risk calpain groups which had prognostic difference. We found the high-risk calpain group had higher B cell infiltration and higher expression of immune checkpoint genes HAVCR2, PDCD1, and TIGHT. The CMap analysis found that the histone deacetylase (HDAC) inhibitor trichostatin A and the PI3K-AKT-mTOR pathway inhibitors LY-294002 and wortmannin might have a therapeutic effect on the high-risk calpain group. The DEGs between calpain groups were identified. Subsequent univariate Cox analysis of each DEG and LASSO-based Cox model obtained a calpain-related prognostic signature. The risk score model of this signature showed good ability to predict the overall survival of HCC patients in TCGA datasets and external validation datasets from the Gene Expression Omnibus database and the International Cancer Genome Consortium database. Conclusion: We found that calpain family members were associated with the progression, prognosis, and drug response of HCC. Our results require further studies to confirm.

Evidence for Calpains in Cancer Metastasis

Localization and Activity of Calmodulin is Involved in Cell–cell Adhesion of Tumor Cells and Endothelial Cells in Response to Hypoxic Stress

Calpain-2 triggers prostate cancer metastasis via enhancing CRMP4 promoter methylation through NF-κB/DNMT1 signaling pathway.

Calumenin and fibulin-1 on tumor metastasis: Implications for pharmacology.

Novel Insights into the Progression and Prognosis of the Calpain Family Members in Hepatocellular Carcinoma: a Comprehensive Integrated Analysis.

Calpain 8 as a potential biomarker regulates the progression of pancreatic cancer via EMT and AKT/ERK pathway

A novel methylated cation channel TRPM4 inhibited colorectal cancer metastasis through Ca<SUP>2+</SUP>/Calpain-mediated proteolysis of FAK and suppression of PI3K/Akt/mTOR signaling pathway

Cathepsins mediate tumor metastasis

Ca v 2.2-NFAT2-USP43 axis promotes invadopodia formation and breast cancer metastasis through cortactin stabilization

Caldesmon: Biochemical and Clinical Implications in Cancer

Calpain-2 regulates hypoxia/HIF-induced plasticity toward amoeboid cancer cell migration and metastasis

Cancer cells sense solid stress to enhance metastasis by CKAP4 phase separation-mediated microtubule branching

Unlocking the Crucial Role of Cancer-Associated Fibroblasts in Tumor Metastasis: Mechanisms and Therapeutic Prospects

Cancer‐associated fibroblasts promote the proliferation and metastasis of colon cancer by mediating the RLIM/PML axis through paracrine COMP

Dysregulation of Calcium Signaling in Tumor Formation and Progression

S100 and annexin proteins identify cell membrane damage as the Achilles heel of metastatic cancer cells

CALB2 drives pancreatic cancer metastasis through inflammatory reprogramming of the tumor microenvironment

KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer

The interactome and spatial redistribution feature of Ca 2+ receptor protein calmodulin reveals a novel role in invadopodia-mediated invasion

The Regulatory Roles of Calcium Channels in Tumors

Stim1-And Orail-Mediated Ca2+ Oscillation Orchestrates Invadopodium Formation And Melanoma Invasion